ArticlebioRxiv : the preprint server for biology2025
The graphene-based affinity cryo-EM grid for the endogenous protein structure determination.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Following recent advancements in cryo-electron microscopy (cryo-EM) instrumentation and software algorithms, the next bottleneck in achieving high-resolution cryo-EM structures arises from sample preparation. To overcome this, we developed a graphene-based affinity cryo-EM grid, the Graffendor (GFD) grid, to target low-abundance endogenous protein complexes. To maintain grid quality and consistency within a single batch of 36 grids, we established a one-step crosslinking batch-production method using genetically modified ALFA nanobody as affinity probe (GFD-A grid). Using low concentrations of β-galactosidase-2xALFA, we demonstrated the GFD-A grid's efficiency in capturing tagged proteins and resolving its cryo-EM structure at 2.71 Å. To test its application for endogenous proteins, we engineered yeast cells with a C-terminal tandem affinity tag (3xALFA-Tev-3xFlag: ATF) at Pop6, a shared component of RNase MRP and RNase P. Cryo-EM structures of RNase MRP and RNase P were resolved at 3.3 Å and 3.0 Å from cell lysates, and 3.6 Å and 3.9 Å from anti-flag elution, respectively. Notably, additional densities were observed in the structures obtained from cell lysates, which were absent in those from the anti-FLAG eluate. These findings establish the GFD-A grid as a robust platform for investigating endogenous proteins, capable of capturing transient interactions and enhancing the resolution of challenging cryo-EM structures with greater efficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.